R Joseph Bender

567 total citations
15 papers, 358 citations indexed

About

R Joseph Bender is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, R Joseph Bender has authored 15 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 8 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in R Joseph Bender's work include Cancer Genomics and Diagnostics (7 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Renal cell carcinoma treatment (4 papers). R Joseph Bender is often cited by papers focused on Cancer Genomics and Diagnostics (7 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Renal cell carcinoma treatment (4 papers). R Joseph Bender collaborates with scholars based in United States, Australia and Canada. R Joseph Bender's co-authors include Michael J. Pishvaian, Andrew Hendifar, Subha Madhavan, Vincent Chung, Jonathan R. Brody, Emanuel F. Petricoin, Vincent J. Picozzi, Lola Rahib, Lynn M. Matrisian and Edik M. Blais and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and Clinical Cancer Research.

In The Last Decade

R Joseph Bender

12 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R Joseph Bender United States 8 240 226 105 102 53 15 358
Ying‐Yang Liao China 11 99 0.4× 141 0.6× 56 0.5× 73 0.7× 53 1.0× 15 308
Binliang Liu China 12 228 0.9× 183 0.8× 134 1.3× 134 1.3× 16 0.3× 34 384
Ghieth A. Kazkaz Saudi Arabia 6 266 1.1× 103 0.5× 113 1.1× 53 0.5× 27 0.5× 8 363
Christopher DiSimone United States 6 271 1.1× 85 0.4× 148 1.4× 114 1.1× 26 0.5× 10 490
Adher Alsayed Saudi Arabia 10 173 0.7× 111 0.5× 33 0.3× 55 0.5× 39 0.7× 19 304
James Lindberg United States 10 247 1.0× 84 0.4× 102 1.0× 100 1.0× 39 0.7× 23 384
Lisle Nabell United States 9 244 1.0× 80 0.4× 89 0.8× 152 1.5× 62 1.2× 25 481
Lorraine Durcan United Kingdom 9 310 1.3× 281 1.2× 83 0.8× 94 0.9× 31 0.6× 10 454
Marek Ziobro Poland 11 277 1.2× 130 0.6× 267 2.5× 196 1.9× 26 0.5× 46 457
Carmen G. Rea Italy 7 207 0.9× 69 0.3× 143 1.4× 92 0.9× 27 0.5× 15 322

Countries citing papers authored by R Joseph Bender

Since Specialization
Citations

This map shows the geographic impact of R Joseph Bender's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Joseph Bender with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Joseph Bender more than expected).

Fields of papers citing papers by R Joseph Bender

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Joseph Bender. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Joseph Bender. The network helps show where R Joseph Bender may publish in the future.

Co-authorship network of co-authors of R Joseph Bender

This figure shows the co-authorship network connecting the top 25 collaborators of R Joseph Bender. A scholar is included among the top collaborators of R Joseph Bender based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Joseph Bender. R Joseph Bender is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Stine, Andrew, et al.. (2025). Simulation of clinical trials of oral treprostinil in pulmonary arterial hypertension using a virtual population. npj Systems Biology and Applications. 11(1). 9–9.
2.
Brar, Gagandeep, Edik M. Blais, R Joseph Bender, et al.. (2019). Multi-omic molecular comparison of primary versus metastatic pancreatic tumours. British Journal of Cancer. 121(3). 264–270. 23 indexed citations
3.
Pishvaian, Michael J., Edik M. Blais, R Joseph Bender, et al.. (2019). A virtual molecular tumor board to improve efficiency and scalability of delivering precision oncology to physicians and their patients. JAMIA Open. 2(4). 505–515. 47 indexed citations
4.
Pishvaian, Michael J., R Joseph Bender, Lola Rahib, et al.. (2018). Molecular Profiling of Patients with Pancreatic Cancer: Initial Results from the Know Your Tumor Initiative. Clinical Cancer Research. 24(20). 5018–5027. 149 indexed citations
5.
Guan, Michelle, R Joseph Bender, Michael J. Pishvaian, et al.. (2018). Molecular and clinical characterization of BRAF mutations in pancreatic ductal adenocarcinomas (PDACs).. Journal of Clinical Oncology. 36(4_suppl). 214–214. 29 indexed citations
6.
Madhavan, Subha, Edik M. Blais, R Joseph Bender, et al.. (2018). A cloud-based virtual tumor board to facilitate treatment recommendations for patients with advanced cancers.. Journal of Clinical Oncology. 36(15_suppl). 6508–6508. 2 indexed citations
7.
Petricoin, Emanuel F., R Joseph Bender, David Halverson, et al.. (2018). Precision medicine for pancreatic cancer patients:preliminary results from the know your tumor program.. Journal of Clinical Oncology. 36(15_suppl). 4126–4126.
8.
Bender, R Joseph, et al.. (2017). Impact of the Australian gender specific thresholds using the Abbott high sensitivity troponin I assay in clinical care. Pathology. 49(5). 514–517. 2 indexed citations
9.
Tuli, Richard, Simon S. Lo, Michael J. Pishvaian, et al.. (2017). Anaplastic Lymphoma Kinase Rearrangement and Response to Crizotinib in Pancreatic Ductal Adenocarcinoma. JCO Precision Oncology. 1(1). 1–5. 10 indexed citations
10.
Pishvaian, Michael J., R Joseph Bender, Lynn M. Matrisian, et al.. (2016). A pilot study evaluating concordance between blood-based and patient-matched tumor molecular testing within pancreatic cancer patients participating in the Know Your Tumor (KYT) initiative. Oncotarget. 8(48). 83446–83456. 49 indexed citations
11.
Herzog, Thomas J., et al.. (2015). 2771 BRCA1 and BRCA2 mutations in 1691 epithelial ovarian tumors identify subgroups with distinct molecular characteristics. European Journal of Cancer. 51. S554–S555. 5 indexed citations
12.
Gatalica, Zoran, et al.. (2015). 213 BRAF mutations are potentially targetable alterations in a wide variety of solid cancers. European Journal of Cancer. 51. S31–S31. 5 indexed citations
13.
Snoo, Femke De, Annuska M. Glas, Arno Floore, et al.. (2009). 0074 Early prognosis prediction: MammaPrint on core-needle biopsies. The Breast. 18. S37–S37.
14.
Fouron, Jean‐Claude, et al.. (1989). Prenatal diagnosis and circulatory characteristics in tetralogy of Fallot with absent pulmonary valve. The American Journal of Cardiology. 64(8). 547–549. 23 indexed citations
15.
Swensson, Richard E., et al.. (1988). Noninvasive Doppler color flow mapping for detection of anomalous origin of the left coronary artery from the pulmonary artery and for evaluation of surgical repair. Journal of the American College of Cardiology. 11(3). 659–661. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026